| ½Ã °£ |
Á¦ ¸ñ |
° »ç |
| Session I - Hot topics in this year |
| 09:00~09:30 |
Cerebral perfusion, autoregulation, and metabolism in patients with diabetes |
ÇѸ²ÀÇ´ë À¯°æÈ£ |
| 09:30~10:00 |
Hepatic insulin resistance |
±¹¸³º¸°Ç¿¬±¸¿ø ¼ÛÁöÇö |
| 10:00~10:30 |
CV risk management; Subclinical CAD in patients with T2DM |
°¡Å縯ÀÇ´ë ±ÇÇõ»ó |
| 10:30~10:50 |
Coffee Break |
|
| Session II - Incretin |
| 10:50~11:20 |
GLP-1, the Mechanism of Action in beta cells |
°è¸íÀÇ´ë ¼Û´ë±Ô |
| 11:20~11:50 |
GLP-1 based treatment in Diabetes |
°¡Å縯ÀÇ´ë Á¶ÀçÇü |
| 11:50~12:20 |
GLP-1 treatment, beyond Diabetes |
°Ç¾çÀÇ´ë ±èº´ÁØ |
| 12:20~13:20 |
Lunch |
|
| Session III - Dilemmas in the insulin treatment of diabetic patients |
| 13:20~13:50 |
Brittle Diabetes in type 1 diabetes mellitus |
¼º±Õ°üÀÇ´ë ±èÀçÇö |
| 13:50~14:20 |
Insulin therapy in highly insulin resistant type 2 diabetes mellitus |
°æÈñÀÇ´ë ¾È±ÔÁ¤ |
| 14:20~14:50 |
New insulin regimens; long acting, inhaled & oral form etc. |
ÀÎÁ¦ÀÇ´ë °í°æ¼ö |
| 14:50~15:10 |
Coffee Break |
|
| Session IV - Diabetic retinopathy |
| 15:10~15:40 |
Interpretation of fundus photograpy |
¼øÃµÇâÀÇ´ë À̼ºÁø |
| 15:40~16:10 |
Update on the treatment of diabetic retinopathy |
¿¬¼¼ÀÇ´ë ±è¼º¼ö |